|
Español
English
|
Dadun >
Browsing by Author Beaumont, J. (Javier)
Showing results 1 to 19 of 19
| Issue Date | Title | Author(s) | | 2006 | Altered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease | Goikoetxea, M.J. (María J.); Beaumont, J. (Javier); Gonzalez, A. (Arantxa); Lopez, B. (Begoña); Querejeta, R. (Ramón); Larman, M. (Mariano); Diez, J. (Javier) |
| 1998 | Altered regulation of smooth muscle cell proliferation and apoptosis in small arteries of spontaneously hypertensive rats | Diez, J. (Javier); Fortuño, M.A. (María Antonia); Zalba, G. (Guillermo); Etayo, J.C. (Juan Carlos); Fortuño, A. (A.); Ravassa, S. (Susana); Beaumont, J. (Javier) |
| 2007 | Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure | Gonzalez, A. (Arantxa); Ravassa, S. (Susana); Loperena, I. (Iñigo); Lopez, B. (Begoña); Beaumont, J. (Javier); Querejeta, R. (Ramón); Larman, M. (Mariano); Diez, J. (Javier) |
| 2011 | Association of the peroxisome proliferator-activated receptor α gene L162V polymorphism with stage C heart failure | Arias, T. (Teresa); Beaumont, J. (Javier); Lopez, B. (Begoña); Zalba, G. (Guillermo); Beloqui, O. (Óscar); Barba, J. (Joaquín); Valencia, F. (Félix); Gomez-Doblas, J.J. (Juan José); De-Teresa, E. (Eduardo); Diez, J. (Javier) |
| 2009 | Biochemical markers of myocardial remodelling in hypertensive heart disease | Gonzalez, A. (Arantxa); Lopez, B. (Begoña); Ravassa, S. (Susana); Beaumont, J. (Javier); Arias, T. (Teresa); Hermida, N. (Nerea); Zudaire, A. (Amaia); Diez, J. (Javier) |
| 2010 | Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5 | Ravassa, S. (Susana); Garcia-Bolao, I. (Ignacio); Zudaire, A. (Amaia); Macias, A. (Alfonso); Gavira, J.J. (Juan José); Beaumont, J. (Javier); Arias, T. (Teresa); Huerta, A. (Ana); Diez, J. (Javier) |
| 2012 | Cardiotrophin-1 in hypertensive heart disease | Gonzalez, A. (Arantxa); Lopez, B. (Begoña); Ravassa, S. (Susana); Beaumont, J. (Javier); Zudaire, A. (Amaia); Gallego, I. (Idoia); Brugnolaro, C. (Cristina); Diez, J. (Javier) |
| 2009 | Cardiovascular translational medicine (III). Genomics and proteomics in heart failure research | Gonzalez, A. (Arantxa); Lopez, B. (Begoña); Beaumont, J. (Javier); Ravassa, S. (Susana); Arias, T. (Teresa); Hermida, N. (Nerea); Zudaire, A. (Amaia); Diez, J. (Javier) |
| 2012 | Contribution of circulating biomarkers to unravel the role of extracellular matrix in hypertensive cardiac remodelling | Beaumont, J. (Javier); Gonzalez, A. (Arantxa); Lopez, B. (Begoña); Ravassa, S. (Susana); Diez, J. (Javier) |
| 2007 | Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure | Lopez, B. (Begoña); Gonzalez, A. (Arantxa); Beaumont, J. (Javier); Querejeta, R. (Ramón); Larman, M. (Mariano); Diez, J. (Javier) |
| 2009 | Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure | Lopez, B. (Begoña); Querejeta, R. (Ramón); Gonzalez, A. (Arantxa); Beaumont, J. (Javier); Larman, M. (Mariano); Diez, J. (Javier) |
| 1999 | Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats | Varo, N. (Nerea); Etayo, J.C. (Juan Carlos); Zalba, G. (Guillermo); Beaumont, J. (Javier); Iraburu, M.J. (María J.); Montiel-Duarte, C. (Cristina); Gil, M.J. (María José); Monreal, I. (Ignacio); Diez, J. (Javier) |
| 2008 | Overexpression of human truncated peroxisome proliferator-activated receptor alpha induces apoptosis in HL-1 cardiomyocytes | Beaumont, J. (Javier); Arias, T. (Teresa); Ravassa, S. (Susana); Diez, J. (Javier) |
| 2004 | Peroxisome proliferator-activated receptor alpha and hypertensive heart disease | Goikoetxea, M.J. (María J.); Beaumont, J. (Javier); Diez, J. (Javier) |
| 2007 | Progress in Hypertensive Heart Disease. Remodeling Mechanisms Involved in the Transition from Hypertrophy to Heart Failure | Beaumont, J. (Javier); Arias, T. (Teresa); Lopez, B. (Begoña); Gonzalez, A. (Arantxa); Ravassa, S. (Susana); Hermida, N. (Nerea); Querejeta, R. (Ramón); Diez, J. (Javier) |
| 2011 | Towards the molecular diagnosis of hypertensive heart disease? | Diez, J. (Javier); Lopez, B. (Begoña); Beaumont, J. (Javier); Gonzalez, A. (Arantxa); Ravassa, S. (Susana) |
| 2007 | Upregulation of myocardial Annexin A5 in hypertensive heart disease: association with systolic dysfunction | Ravassa, S. (Susana); Gonzalez, A. (Arantxa); Lopez, B. (Begoña); Beaumont, J. (Javier); Querejeta, R. (Ramón); Larman, M. (Mariano); Diez, J. (Javier) |
| 2000 | Vascular oxidant stress: molecular mechanisms and pathophysiological implications | Zalba, G. (Guillermo); Beaumont, J. (Javier); San-Jose, G. (Gorka); Fortuño, A. (A.); Fortuño, M.A. (María Antonia); Diez, J. (Javier) |
| 2001 | Vascular oxidative stress and endothelial dysfunction | Zalba, G. (Guillermo); Gonzalez, A. (Arantxa); Beaumont, J. (Javier); San-Jose, G. (Gorka); Moreno, M.U. (María Ujué); Lopez, B. (Begoña); Ravassa, S. (Susana); Muñiz, P. (Paula); Fortuño, A. (A.); Fortuño, M.A. (María Antonia); Diez, J. (Javier) |
Showing results 1 to 19 of 19
|